Financial Perspectives’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-250
| Closed | -$55 | – | 713 |
|
|
2023
Q2 | $55 | Hold |
250
| – | – | ﹤0.01% | 674 |
|
|
2023
Q1 | $79 | Hold |
250
| – | – | ﹤0.01% | 670 |
|
|
2022
Q4 | $295 | Hold |
250
| – | – | ﹤0.01% | 655 |
|
|
2022
Q3 | $233 | Hold |
250
| – | – | ﹤0.01% | 672 |
|
|
2022
Q2 | $275 | Hold |
250
| – | – | ﹤0.01% | 667 |
|
|
2022
Q1 | $440 | Hold |
250
| – | – | ﹤0.01% | 662 |
|
|
2021
Q4 | $583 | Hold |
250
| – | – | ﹤0.01% | 625 |
|
|
2021
Q3 | $920 | Hold |
250
| – | – | ﹤0.01% | 619 |
|
|
2021
Q2 | $1.85K | Sell |
250
-1,225
| -83% | -$9.07K | ﹤0.01% | 612 |
|
|
2021
Q1 | $250K | Buy |
1,475
+1,225
| +490% | +$208K | 0.01% | 376 |
|
|
2020
Q4 | $1.52K | Hold |
250
| – | – | ﹤0.01% | 559 |
|
|
2020
Q3 | $1.77K | Hold |
250
| – | – | ﹤0.01% | 503 |
|
|
2020
Q2 | $1.66K | Buy |
+250
| New | +$1.66K | ﹤0.01% | 493 |
|